BrePco Biopharma Limited   Report issue

For profit Phase 3
Founded: Douglas Ireland (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2015
NCT01482559
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now